Klin Farmakol Farm. 2015;29(1):5-7

Consumption of antibiotics and antifungals in patients with severe burns requiring intensive care

Břetislav Lipový1,2, Hana Řihová1, Jiří Jarkovský3, Tomáš Kempný1, Pavel Brychta1,2
1 Klinika popálenin a rekonstrukční chirurgie FN Brno
2 Lékařská fakulta Masarykovy Univerzity Brno
3 Institut biostatistiky a analýz Masarykovy Univerzity Brno

Infectious complications currently represent a serious medical and economic issue not only in severely burnt patients, but also in those

in intensive care in general. In the past decade, there has been a dramatic increase in the number of resistant microorganisms. In this

respect, an optimal handling of antimicrobial policy poses one of the most pressing problems in current intensive care of severely and

critically burnt patients. The article presents the results of a European study focused on the consumption of individual antimicrobial

agents that can also serve as an indicator of resistance of particular microorganisms.

Keywords: burns, antibiotics, antifungals

Published: March 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lipový B, Řihová H, Jarkovský J, Kempný T, Brychta P. Consumption of antibiotics and antifungals in patients with severe burns requiring intensive care. Klin Farmakol Farm. 2015;29(1):5-7.
Download citation

References

  1. Leseva M, Arguirova M, Nashev D, Zamfirova E, Hadzhyiski O. Nosocomial infection in burn patients: etiology, antimicrobial resistance, means to control. Ann Burns Fire Disasters. 2013; 26(1): 5-11.
  2. Soares de Macedo JL, Santos JB. Nosocomial infections in a Brazilian Burn Unit. Burns. 2006; 32(4): 477-481. Go to original source... Go to PubMed...
  3. Lipový B, Řihová H, Hanslianová M, Burgetová D, Kaloudová Y, Suchánek I, Brychta P. Změna bakteriálního spektra na ranných plochách u těžce popálených pacientů. Epidemiol. Mikrobiol. Imunol. 2010; 59(1): 34-38. Go to PubMed...
  4. Greenhalgh DG, Saffle JR, Holmes JH. 4th, Gamelli RL, Palmieri TL, Horton JW, Tompkins RG, Traber DL, Mozingo DW, Deitch EA, Goodwin CW, Herndon DN, Gallagher JJ, Sanford AP, Jeng JC, Ahrenholz DH, Neely AN, O'Mara MS, Wolf SE, Purdue GF, Garner WL, Yowler CJ, Latenser BA. American Burn Association Consensus Conference on Burn Sepsis and Infection Group. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007; 28(6): 776-790. Go to original source...
  5. Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns. 2014; 40(3): 402-407. Go to original source... Go to PubMed...
  6. Lipový B, Řihová H, Hanslianová M, Gregorová N, Suchánek I, Brychta P. Prevalence and resistence of Pseudomonas aeruginosa in severely burned patients: A 10-year retrospective study. Acta Chir Plast. 2010; 52(2-4): 39-43. Go to PubMed...
  7. Messadi AA, Lamia T, Kamel B, Salima O, Monia M, Saida BR. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004. Burns. 2008; 34(8): 1098-102. Go to original source... Go to PubMed...
  8. Kolář M, Htoutou Sedláková M, Šenkyříková M, Hanulík V, Honig P. Vliv rezistence Pseudomonas aeruginosa na antibioterapii. Klin Farmakol Farm 2013; 27(3-4): 101-105.
  9. Lipový B, Řihová H, Hanslianová M, Gregorová N, Kaloudová Y, Mager R, Suchánek I, Brychta P. Kolistin v léčbě multirezistentních kmenů Pseudomonas aeruginosa u těžce popálených pacientů. Epidemiol. Mikrobiol. Imunol. 2010; 59(4): 183-188.
  10. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Porphylactic antibiotics for burns patients: systematic review and meta analysis. BMJ 2010; 340: c241. Go to original source... Go to PubMed...
  11. Ugburo AO, Atoyebi OA, Oyeneyin JO, Sowemimo GO. An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos university teaching hospital. Burns 2004; 30: 43-48. Go to original source... Go to PubMed...
  12. Alp E, Coruh A, Gunay GK, Yontar Y, Doganay M. Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital. J Burn Care Res. 2012; 33(3): 379-385. Go to original source...
  13. Liodaki E, Kalousis K, Schopp BE, Mailänder P, Stang F. Prophylactic antibiotic therapy after inhalation injury. Burns. 2014 Mar. In press. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.